Publications
Detailed Information
Analysis of differences in human leukocyte antigen between the two wellcome trust case control consortium control datasets
Cited 0 time in
Web of Science
Cited 0 time in Scopus
- Authors
- Issue Date
- 2019-01
- Publisher
- 한국유전체학회
- Citation
- Genomics & Informatics, Vol.17 No.3, p. e29
- Abstract
- © 2019, Korea Genome Organization.The Wellcome Trust Case Control Consortium (WTCCC) study was a large genome-wide association study that aimed to identify common variants associated with seven diseases. That study combined two control datasets (58C and UK Blood Services) as shared controls. Prior to using the combined controls, the WTCCC performed analyses to show that the genomic content of the control datasets was not significantly different. Recently, the analysis of human leukocyte antigen (HLA) genes has become prevalent due to the development of HLA imputation technology. In this project, we extended the between-control homogeneity analysis of the WTCCC to HLA. We imputed HLA information in the WTCCC control dataset and showed that the HLA content was not significantly different between the two control datasets, suggesting that the combined controls can be used as controls for HLA fine-map-ping analysis based on HLA imputation.
- ISSN
- 1598-866X
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.